SPDR® S&P Biotech ETF (XBI)

Add to Watchlists
Create an Alert
81.82 +0.50  +0.61% NYSE Arca Dec 15, 20:00 Delayed 2m USD
View Full Chart
XBI Price Chart

XBI Performance

  Total Return (Price) Total Return (NAV) Cat. Total Return (NAV) % Rank in Cat. (NAV)
1M 2.21% 2.17% 2.87% 84
3M -2.20% -2.16% -0.44% 74
6M 14.58% 14.57% 6.52% 10
YTD 38.55% 38.53% 22.71% 7
1Y 32.43% 32.51% 22.35% 12
3Y 12.24% 12.23% 6.14% 15
5Y 23.28% 23.26% 16.85% 1
10Y 15.56% 15.57% 11.68% 5
As of Dec. 15, 2017. Returns for periods of 1 year and above are annualized.

XBI Asset Allocation

Type % Net % Long % Short
Cash 0.11% 0.11% 0.00
Stock 99.89% 99.89% 0.00
Bond 0.00 0.00 0.00
Convertible 0.00 0.00 0.00
Preferred 0.00 0.00 0.00
Other 0.00 0.00 0.00
As of Dec. 14, 2017

XBI Region Exposure

Americas 100.0%
North America 100.0%
Latin America 0.00
Greater Europe 0.00
United Kingdom 0.00
Europe Developed 0.00
Europe Emerging 0.00
Africa/Middle East 0.00
Greater Asia 0.00
Japan 0.00
Australasia 0.00
Asia Developed 0.00
Asia Emerging 0.00
Market Classification
% Developed Markets 100.0%
% Emerging Markets 0.00
As of Dec. 13, 2017. Region breakdown data is calculated by using the long position holdings of the portfolio.

XBI Stock Sector Exposure

Basic Materials 0.00
Communication Services 0.00
Consumer Cyclical 0.00
Consumer Defensive 0.00
Energy 0.00
Financial Services 0.00
Healthcare 100.0%
Industrials 0.00
Real Estate 0.00
Technology 0.00
Utilities 0.00
As of Dec. 14, 2017

XBI Stock Market Capitalization

Giant 5.89%
Large 8.47%
Medium 28.43%
Small 37.89%
Micro 19.32%
As of Dec. 14, 2017

XBI Stock Style Exposure

Large Cap Value 2.09%
Large Cap Blend 4.02%
Large Cap Growth 9.51%
Mid Cap Value 0.00
Mid Cap Blend 2.42%
Mid Cap Growth 26.23%
Small Cap Value 1.86%
Small Cap Blend 12.43%
Small Cap Growth 41.44%
As of Dec. 14, 2017
View More Holdings

XBI Top 10 Holdings

Symbol Name % Weight Price % Chg
ALNY Alnylam Pharmaceuticals Inc 3.32% 125.59 +1.56%
BLUE bluebird bio Inc 2.92% 182.95 -0.76%
SRPT Sarepta Therapeutics Inc 2.47% 52.60 -1.96%
NBIX Neurocrine Biosciences Inc 2.41% 70.49 +0.10%
EXAS Exact Sciences Corp 2.39% 51.56 +0.66%
SAGE Sage Therapeutics Inc 2.31% 162.32 +2.71%
ABBV AbbVie Inc 2.23% 97.45 +1.19%
UTHR United Therapeutics Corp 2.22% 137.41 +1.20%
AVXS AveXis Inc 2.11% 98.92 -0.02%
JUNO Juno Therapeutics Inc 2.09% 44.68 +1.15%
As of Dec. 14, 2017
Advertisement

XBI One Page Reports

XBI Basic Info

Style
Equity Style Mid Cap/Growth
Broad Asset Class Sector Equity
Broad Category Equity
Category Name Health
Prospectus Objective Specialty - Health
Fund Owner Firm Name SPDR State Street Global Advisors
Benchmark Index
S&P Biotechnology Select Industry TR USD
100.0%

XBI Manager Info

Name Tenure
Karl Schneider 3.00 yrs
Michael Feehily 6.01 yrs
Raymond Donofrio 0.83 yrs

XBI Net Fund Flows

1M -76.29M
3M -124.92M
6M 452.01M
YTD 574.38M
1Y 71.35M
3Y 1.847B
5Y 1.968B
10Y 2.246B
As of Nov. 30, 2017

XBI Risk Info

Beta (5Y) 1.547
Max Drawdown (All) 49.25%
Historical Sharpe (10Y) 0.7119
Historical Sortino (All) 1.007
30-Day Rolling Volatility 21.95%
Daily Value at Risk (VaR) 1% (All) 4.88%
Monthly Value at Risk (VaR) 1% (All) 21.34%

XBI Fundamentals

Dividend Yield TTM (12-15-17) 0.23%
SEC Yield (12-14-17) 0.14%
Weighted Average PE Ratio --
Weighted Average Price to Sales Ratio 9.405
Weighted Average Price to Book Ratio 5.680
Weighted Median ROE -17.58%
Weighted Median ROA -21.21%
Forecasted Dividend Yield 0.19%
Forecasted PE Ratio 22.08
Forecasted Price to Sales Ratio 6.307
Forecasted Price to Book Ratio 4.691
Number of Holdings 103
As of Dec. 14, 2017

XBI Growth Estimates

Forecasted 5 Yr Earnings Growth 11.66%
Forecasted Book Value Growth 10.07%
Forecasted Cash Flow Growth 17.20%
Forecasted Earnings Growth 15.34%
Forecasted Revenue Growth 22.46%
As of Dec. 14, 2017

XBI Comparables

Edit

XBI Attributes

Key Dates
Inception Date 1/31/2006
Termination Date
Last Annual Report Date 6/30/2017
Last Prospectus Date 10/31/2017
Attributes
Exchange Traded Share Yes
Exchange Traded Note No
Enhanced Index Fund No
Index Fund Yes
Inverse Fund No
Leveraged Fund No
Fund of Funds No
Currency Hedged Fund No
Synthetic Replication Fund No
Has Dividend Investment Plan Yes
General Availability
Available for Insurance Product No
Available for Retirement Plan No
Available for RRSP No

XBI Excel Add-In Codes

  • Name: =YCI("XBI","name")
  • Broad Asset Class: =YCI("XBI", "broad_asset_class")
  • Broad Category: =YCI("XBI", "broad_category_group")
  • Prospectus Objective: =YCI("XBI", "prospectus_objective")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.